The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A survey of thousands of tumor exomes and transcriptomes to expand clinical opportunities for crizotinib.
Emma Bowden
No relevant relationships to disclose
Sean Eddy
No relevant relationships to disclose
Paul Williams
No relevant relationships to disclose
Nikolay Khazanov
No relevant relationships to disclose
Armand Bankhead
No relevant relationships to disclose
Dinesh Cyanam
No relevant relationships to disclose
Peter Wyngaard
No relevant relationships to disclose
Dan Rhodes
No relevant relationships to disclose